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Abstract
Objective: To determine whether L-arginine has any
salutary effects on wound immune cell function follow-
ing trauma-hemorrhage. Background: Depressed wound
immune function contributes to an increased incidence
of wound infections following hemorrhage. Although
administration of L-arginine has been shown to restore
depressed cell-mediated immune responses following
hemorrhage potentially by maintaining organ blood
flow, it remains unknown whether L-arginine has any
salutary effects on the depressed local immune response
at the wound site. Methods: Male mice were subjected to
a midline laparotomy and polyvinyl sponges were im-
planted subcutaneously in the abdominal wound prior to
hemorrhage (35 B 5 mm Hg for 90 min and resuscita-
tion) or sham operation. During resuscitation mice re-
ceived 300 mg/kg body weight L-arginine or saline (vehi-
cle). Sponges were harvested 24 h thereafter, wound
fluid collected and wound immune cells cultured for 24 h
in the presence of LPS. Pro- (IL-1ß, IL-6) and anti-inflam-
matory (IL-10) cytokines were determined in the super-
natants and the wound fluid. In addition, wounds were
stained for IL-6 immunohistochemically. In a separate set
of animals, skin and muscle blood flow was determined
by microspheres. Results: The capacity of wound im-
mune cells to release IL-1ß and IL-6 in vitro was signifi-
cantly depressed in hemorrhaged mice receiving vehi-
cle. Administration of L-arginine, however, improved
wound immune cell function. In contrast, in vivo the
increased IL-6 release at the wound site was decreased in
L-arginine-treated mice following hemorrhage. More-
over, IL-10 levels were significantly increased in the
wound fluid in hemorrhaged animals receiving L-argi-
nine compared to vehicle-treated mice. In addition, the
depressed skin and muscle blood flow after hemorrhage
was restored by L-arginine. Conclusions: Thus, L-argi-
nine might improve local wound cell function by de-
creasing the inflammatory response at the wound site.
Since L-arginine protected wound immune cell function
this amino acid might represent a novel and useful
adjunct to fluid resuscitation for decreasing wound com-
plications following hemorrhage.
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Several studies indicate that trauma and hemorrhagic
shock lead to profound alterations of both immune re-
sponses and organ function [1]. This depression of im-
mune responses has been shown to be associated with an
increased morbidity and mortality from subsequent sep-
sis [2, 3]. Moreover, endothelial cell dysfunction occurs
early after the onset of hemorrhagic shock and is mani-
fested by reduced release of endothelium-derived NO
[4]. Vascular endothelium cell-derived NO is responsible
for vasorelaxation [5], for inhibiting platelet aggregation
[6], and neutrophil infiltration [7]. The reduced release
of endothelium-derived NO following trauma-hemor-
rhage is most likely due to the decreased activity of
endothelial constitutive NO synthase (cNOS) [8]. Endo-
thelial cell dysfunction appears to contribute to further
depression of organ function and immune responses fol-
lowing trauma-hemorrhage [4]. Recent studies indicate
that administration of L-arginine, the substrate for
cNOS, during resuscitation following trauma-hemor-
rhage maintained organ blood flow, decreased hepatic
injury and restored the depressed cell-mediated immune
responses [9–12].
Similarly, markedly depressed wound immune cell
function has been shown following trauma and hemor-
rhagic shock. These changes in wound immune cell func-
tion persist for up to 3 days after resuscitation [13] and
result in an increased rate of wound infections. Since salu-
tary effects of L-arginine on organ blood flow and sys-
temic cell-mediated immune responses have been demon-
strated following trauma-hemorrhage we hypothesized
that administration of L-arginine might also maintain
blood flow to the wound thereby improving the depressed
local wound immune cell function. Therefore, the aim of
our study was to determine whether or not infusion of L-
arginine during resuscitation following trauma and hem-
orrhage has any beneficial effects on the depressed wound
immune cell function following trauma-hemorrhage.
Material and Methods
Animals
Inbred male C3H/HeN mice (Charles River Laboratories, Ger-
many), 7 weeks of age (24–27 g BW) were used in this study. All
procedures were carried out in accordance with the guidelines set
forth in the Animal Welfare Act and the Guide for the Care and Use
of Laboratory Animals by the Regierung von Oberbayern and the
Ludwig Maximilians University.
Experimental Groups
Male mice were randomized into three groups (n = 6–8 per
group): The mice in group 1 underwent trauma alone (sham ani-
mals), while the mice in groups 2 and 3 were subjected to the trauma-
hemorrhage procedure (hemorrhage). Group 2 received vehicle
whereas group 3 was treated with L-arginine.
Trauma Procedure and Sponge Implantation
Mice were lightly anesthetized with methoxyflurane (Metofane,
Pitman-Moore, Mundelein, Ill., USA), restrained in a supine posi-
tion, and the skin was disinfected using 75% ethanol. A 2.5-cm mid-
line laparotomy (i.e. trauma induced) was performed and the muscu-
lar layer was then closed aseptically using 6-0 Ethilon sutures (Ethi-
con, Inc., Somerville, N.J., USA). Following this polyvinyl sponges
(0.5 cm in diameter) (M-Pact, Eudora, USA) were aseptically im-
planted subcutaneously (3 per animal) next to the incision site avoid-
ing contamination or infection of the wound site. The skin incision
was then closed using 4.0 sutures.
Hemorrhage Procedure
Following the midline laparotomy and sponge implantation, both
femoral arteries were aseptically cannulated with polyethylene 10
tubing (Clay-Adams, Parsippany, N.J., USA) using a minimal dissec-
tion technique. Blood pressure was constantly monitored by attach-
ing one of the catheters to a blood pressure analyzer (Digi-MedTM,
Louisville, Ky., USA). Upon awakening, the animals were bled rap-
idly through the other catheter to a mean arterial blood pressure (BP)
of 35 B 5 mm Hg (BP prehemorrhage was 95 B 5 mm Hg), which
was maintained for 90 min. At the end of that period, the animals
were resuscitated intraarterially with lactated Ringer’s solution (4
times the shed blood volume over 30 min) to provide adequate fluid
resuscitation. Lidocaine was applied to the groin incision sites, the
catheters were removed, the vessels ligated and the groin incisions
closed. Sham-operated animals underwent the same groin dissection,
which included ligation of both femoral arteries; however, neither
hemorrhage nor fluid resuscitation were carried out. No mortality
was observed in this trauma-hemorrhage model.
L-Arginine Administration
At the beginning of resuscitation in hemorrhaged animals, either
saline (vehicle) or L-arginine (300 mg/kg body weight in 1.0 ml nor-
mal saline) (Sigma Chemical Co., St. Louis, Mo., USA) was infused
via the femoral catheter over a period of 15 min at a constant rate.
The dose of 300 mg/kg body weight L-arginine was chosen in accor-
dance with our previous studies which demonstrated salutary effects
on the depressed organ blood flow and the depressed cell-mediated
immune responses following trauma-hemorrhage with L-arginine
administration [10, 11].
Preparation of Wound Exudate Cells from the Sponges
The animals were sacrificed by methoxyflurane overdose on the
first postoperative day after hemorrhage and resuscitation or sham
operation. The sponges were dissected free from the surrounding
connective tissue using sterile surgical methods. Wound exudate
from the sponges was harvested as previously described [14, 15]. In
brief, the sponges from each animal were combined and centrifuged
at 300 g for 15 min at 4°C for isolation of the wound fluid. Follow-
ing this the sponges were transferred into a plastic bag with ice-
cold phosphate-buffered saline. The sponges were repeatedly com-
pressed and the resultant cell suspension was centrifuged at 300 g for
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15 min at 4 °C. The cell pellet of wound exudate cells was diluted to
1.5 ! 106 cells/ml in RPMI 1640 medium containing 10% fetal calf
serum and gentamicin. One milliliter of this cell suspension was cul-
tured on a 24-well plate for 24 h at 37°C, 5% CO2 and 90% humidity
in the presence of 10 Ìg/ml of lipopolysaccharide A (LPS). After incu-
bation, the cell suspension was centrifuged at 300 g for 15 min at
4°C, the supernatants harvested and stored at –80°C until assayed
for IL-1ß, IL-6, and IL-10 levels.
Assessment of Interleukin-1ß, Interleukin-6, and Interleukin-10
Interleukin-1ß, Interleukin-6, and IL-10 levels in wound cell
supernatants and wound fluid were determined using the Sandwich-
Enzyme Linked Immunoassay (ELISA) technique as described pre-
viously [16].
Immunhistochemistry
Sections of the wound site were fixed in 4% paraformaldehyd.
Paraffine blocks of specimens were cut at 1–2 Ìm. The specimens
were stained using avidine-biotine-complex. In brief, the sections
were incubated with primary polyclonal goat IL-6 anti-mouse anti-
body (R&D Systems) at dilution of 1:200 for 1 h at room tempera-
ture. Following this, a biotinylated anti-goat antibody (Dianova,
Hamburg, Germany) was added at a dilution of 1:4,000 for 30 min at
room temperature. Then, the sections were incubated at room tem-
perature for 30 min with a streptavidine-peroxidase-conjugated anti-
body at a dilution of 1:200. 3)amino-9)ethyl carbazole (Sigma) was
added for 8 min to initiate color development. The slides were evalu-
ated double-blinded by two separate investigators.
Determination of Skin and Muscle Blood Flow
In a separate set of animals rats were used to measure the effect of
L-arginine on the depressed skin and muscle blood flow following
trauma-hemorrhage. Those experiments were performed in rats since
the microspheres method has been established in rats in our hands
previously [11]. Moreover, similar changes in organ blood flow have
been demonstrated in mice and rats following severe blood loss [17].
The non-heparinized model of trauma-hemorrhage and crystalloid
resuscitation in the rat used in the present study has been previously
described in detail by us [11]. Briefly, male Sprague-Dawley rats
(Charles River Laboratories, Germany) (260–325 g) were anesthe-
tized with methoxyflurane (Pitman-Moore, Mundelein, Ill., USA)
and a 5-cm ventral midline laparotomy was performed to induce
soft-tissue trauma prior to hemorrhage. The abdominal incision was
then closed in two layers following which both femoral arteries and
one femoral vein were cannulated with polyethylene (PE) 50 tubing
(Clay-Adams, Parsippany, N.J., USA). Immediately after recovery
from anesthesia, the animals were bled to a mean arterial pressure
(MAP) of 40 mm Hg within 10 min. This pressure (40 mm Hg) was
maintained until 40% of the shed blood volume was returned in the
form of Ringer’s lactate (RL) At that time (F1.5 h from the onset of
hemorrhage), the rats were resuscitated intravenously with 4 times
(F45 ml/rat) the volume of maximal bleedout with RL over 60 min.
At the beginning of resuscitation L-arginine (300 mg/kg BW in 1.0 ml
normal saline) or normal saline was infused via the femoral venous
catheter over a period of 15 min. Skin and muscle blood flow was
determined 4 h after the completion of fluid resuscitation or sham
operation using the microspheres method as previously described
[18]. In brief, a PE-10 tubing was placed via the carotid artery in the
left ventricle. Strontium-85-labeled microspheres (13.8 B 0.6 Ìm
diameter; specific activity, 12.3 mCi/g) were suspended in 10% dex-
Table 1. Total number of wound immune cells and percentage of
M∑ and PMN in wound cells harvested from the sponges 24 h fol-
lowing hemorrhage or sham operation
Cells, !106 M∑, % PMN,%
6.7B0.8 9.9B1.0 90.1B1.1
Hemorrhage vehicle 9.7B2.5 7.0B0.9 93.0B0.9
Hemorrhage L-arginine 10.5B1.5 7.5B1.3 92.5B1.3
Total number of wound immune cells and percentage of M∑ and
PMN in the wound exudate cells harvested from sponges which had
been implanted in male mice (C3H/HeN) (n = 6/group). The sponges
were harvested on the first postoperative day after hemorrhage or
sham operation. Hemorrhaged animals were treated with saline (ve-
hicle) or L-arginine at the beginning of resuscitation.
Values are presented as means B SEM.
tran containing 0.05% Tween-80 surfactant to prevent aggregation.
An estimated 150,000 microspheres were injected into each animal.
Skin and muscle from the abdominal wall were removed, washed,
weighted and the radioactivity was counted. Following this, muscle
and skin blood flow was calculated. None of the animals died during
the study period, and the rats were sacrificed at the end of the experi-
ment by an overdose of methoxyflurane. There were 6–8 animals in
each group at each time point.
Statistical Analysis
The results are presented as mean B SEM. One way ANOVA
followed by the Tukey’s test as a post hoc test for multiple compari-
sons was used to determine the significance of the differences
between experimental means. Significance between the colony form-
ing units were determined using Student’s t test. A p value !0.05 was
considered statistically significant.
Results
The Distribution of Polymorphonuclears (PMN) and
Macrophages (M∑) at the Wound Site
The number of wound exudate cells (table 1) as well as
the percentage of M∑ and PMN was similar in hemor-
rhaged and sham-operated animals. Moreover, adminis-
tration of L-arginine did not affect the number of wound
exudate cells or the distribution of PMN and M∑ within
the wound immune cells.
Proinflammatory Cytokine Release by Wound
Exudate Cells
There was a significant decrease in the LPS stimulated
release of IL-1ß (fig. 1A) in vitro by wound exudate cells
following hemorrhage (–55.3% compared to sham-oper-
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Fig. 1. Release of IL-1ß (A) and IL-6 (B) by wound exudate cells
harvested from subcutaneous sponges from male C3H/HeN mice
(n = 5–7/group) on the first postoperative day following sham opera-
tion (Sham) or hemorrhage and resuscitation (Hem). At the begin-
ning of resuscitation, normal saline (veh) or 300 mg/kg BW L-argi-
nine (L-Arg) was infused. The cells were cultured for 24 h in the pres-
ence of 10 Ìg/ml lipopolysaccharide A. The release of IL-1ß and of
IL-6 was determined by ELISA. Data are presented as mean B SEM
and compared with one-way analysis of variance (ANOVA) and
Tukey’s test as a post-hoc test. * p ! 0.05 versus Sham.
Fig. 2. Immunhistochemistry slides of the wound site on the first
postoperative day following sham operation (Sham) or hemorrhage
and resuscitation (Hem) stained for IL-6. At the beginning of resusci-
tation, normal saline (veh) or 300 mg/kg BW. L-arginine (L-Arg) was
infused. A representative slide for each study group is shown.
ated animals, p ! 0.05). Administration of L-arginine dur-
ing resuscitation, however, attenuated the depressed IL-
1ß release by wound exudate cells (+49.5% compared to
hemorrhaged animals receiving vehicle).
The LPS-stimulated release of IL-6 (fig. 1B) was mark-
edly depressed on the first postoperative day following
hemorrhagic shock (–74.2% compared to sham-operated
animals, p ! 0.05). As demonstrated in figure 1B, the
depressed IL-6 release by wound exudate cells in vitro was
restored with L-arginine administration (+153.4% com-
pared to hemorrhaged animals receiving vehicle).
IL-6 at the Wound Site in vivo
Immunhistochemical sections stained for IL-6 indicate
that following hemorrhage IL-6 was increased around the
wound incision site in vivo. L-Arginine, however, de-
creased IL-6 at the wound. One representative slide for
each group is shown (fig. 2A–C).
Proinflammatory Cytokines in the Wound Fluid
There were no significant differences evident in the
concentration of the proinflammatory cytokines IL-1ß
and IL-6 in the wound fluid among the three study groups
(table 2).
IL-1ß, pg/ml
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Fig. 3. IL-10 level in the wound fluid harvested from subcutaneous
sponges from male C3H/HeN mice (n = 5–7/group) on the first post-
operative day following sham operation (Sham) or hemorrhage and
resuscitation (Hem). At the beginning of resuscitation, normal saline
(veh) or 300 mg/kg BW. L-arginine (L-Arg) was infused. IL-10 was
determined by ELISA. Data are presented as mean B SEM and com-
pared with one-way analysis of variance (ANOVA) and Tukey’s test
as a post-hoc test. * p ! 0.05 versus Sham, † p ! 0.05 versus Hem.
Fig. 4. Effect of L-arginine administration on skin (A) and muscle
(B) blood flow at 4 h following sham operation (Sham) or hemorrhage
and resuscitation (Hem). At the beginning of resuscitation, normal
saline (veh) or 300 mg/kg BW L-arginine (L-Arg) was infused. Data
are presented as mean B SEM and compared with one-way analysis
of variance (ANOVA) and Tukey’s test as a post-hoc test. * p ! 0.05
versus Sham, † p ! 0.05 versus Hem.
Table 2. Concentration of IL-1ß and IL-6 in the wound fluid on the






IL-6, pg/ml 22.8B7.1 15.8B3.7 27.6B14.6
Concentration of IL-1ß and IL-6 in the wound fluid harvested
from animals on the first postoperative day after hemorrhage or
sham operation. Hemorrhaged animals were treated with saline (ve-
hicle) or L-arginine at the beginning of resuscitation. IL-1ß and IL-6
were measured in the wound fluid by ELISA.
Values are presented as means B SEM.
Antiinflammatory Cytokines in the Wound Fluid
Similar levels of IL-10 were detectable in the wound
fluid of sham animals and hemorrhaged animals receiving
vehicle (fig. 3). In contrast to the proinflammatory cyto-
kine levels, administration of L-arginine, significantly
increased IL-10 levels in the wound fluid following trau-
ma-hemorrhage (+382% compared to hemorrhaged ani-
mals receiving vehicle).
Effects of L-Arginine on Skin and Muscle Blood Flow
Skin (fig. 4A) and muscle (fig. 4B) blood flow was sig-
nificantly decreased in hemorrhaged animals receiving
vehicle at 4 h after resuscitation (–55.6 and –55.7% com-
pared to sham-operated animals, respectively, p ! 0.05).
L-arginine administration during crystalloid resuscitation
in trauma-hemorrhaged animals restored organ blood
flow in the skin and muscle (+175 and +152% compared
to sham-operated animals, respectively, p ! 0.05).
Discussion
Wound infections remain the leading complication fol-
lowing severe trauma [19] accounting for approximately a
quarter of the total number of nosocomial infections [20].
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Furthermore, surgical wound infections continue to con-
sume a considerable portion of health care finances [21].
In this respect, studies by Olson et al. demonstrate that
a reduction of the overall wound infection rate from
4.2 to 2.5% at one medical center saved approximately
USD3 million on hospital room costs during a 10-year
period [22]. In addition, wound infections are a potential
source for increasing morbidity and mortality in surgical
patients as a result of subsequent tissue inflammation and
infection, the latter being especially common in the pres-
ence of compromised immune functions seen in the criti-
cally ill patient [23–25]. In experimental studies, de-
pressed wound immune cell function has been shown fol-
lowing hemorrhagic shock which persists for up to three
days [13]. Moreover, the depressed wound immune cell
function following severe blood loss has been found to be
associated with an increased susceptibility of hemor-
rhaged animals to wound infection [26]. Antibiotics failed
to decrease the rate of wound infection in hemorrhaged
animals [26, 27] further supporting the notion that altera-
tions in host defense mechanisms at the wound site con-
tribute to wound infections. Since administration of L-
arginine following trauma-hemorrhage restored the de-
pressed splenic and peritoneal macrophage function as
well as splenocyte responses [10, 12] it was the aim of the
present study to determine whether L-arginine also exhib-
its any salutary effects on the depressed wound immune
cell function under such conditions.
To study whether L-arginine attenuates immune cell
dysfunction at the wound site, polyvinyl sponges were
implanted in the laparotomy wound and wound exudate
cells were harvested on the first postoperative day.
Sponges were utilized in the present study since wound
exudate cells cannot be harvested directly from the wound
site. Furthermore, implantation of sponges is a commonly
used and well described experimental method for obtain-
ing wound exudate cells [13–15, 28]. It should be pointed
out that the wound exudate cells assessed in the present
study represent an unpurified (mixed) cellular sample
composed of primarily PMN and M∑. This was done in
an attempt to simulate the in vivo setting of wound exu-
date cells and their immune response to a second stimulus
in vitro.
The results of the present study indicate that wound
immune cell cytokine release in response to LPS was
markedly depressed in vehicle-treated animals following
trauma-hemorrhage on the first postoperative day. Ad-
ministration of L-arginine at the beginning of resuscita-
tion, however, attenuated the depressed wound immune
cell function 24 h following hemorrhage. Since the distri-
bution of wound exudate cells was unaffected by hemor-
rhage or L-arginine administration the observed improve-
ment in the cytokine release in L-arginine treated animals
does not appear to be due to variations in the distribution
of wound exudate cells. Wound cells were harvested on
the first postoperative day since previous studies demon-
strate maximal depression of wound immune cell func-
tion at this time point following shock.
Interleukin-1ß and IL-6 were determined in the
present study since both cytokines have been shown to be
involved in the wound healing process in experimental
wound models and in surgical patients [14, 15]. Interleu-
kin-1 and IL-6 stimulate leukocyte chemotaxis, T and B
cell activity and PMN bactericidal activity [29–31]. A
decreased capacity of wound cells to release proinflamma-
tory cytokines following glucocorticoid treatment in mice
has been reported to be associated with an increased rate
of wound complications [32, 33]. In addition, the capacity
of wound exudate cells to release proinflammatory cyto-
kines in response to LPS was used as a marker to deter-
mine the responsiveness of wound exudate cells to a sec-
ond stimulus following hemorrhagic shock or sham opera-
tion. Furthermore, a decreased release of proinflammato-
ry cytokines by splenic and peritoneal M∑ in response to
subsequent stimulation has been demonstrated following
hemorrhagic shock [1]. This hyporesponsiveness of splen-
ic and peritoneal M∑ following hemorrhage was associat-
ed with dysfunction of these cells (i.e., impaired antigen
presentation and cytotoxicity) [34, 35]. Normalization of
the depressed cell-mediated immune responses by various
immunomodulatory agents, i.e. flutamide [3], DHEA
[36], metoclopramide [37] etc., decreased the susceptibili-
ty of hemorrhaged animals to polymicrobial sepsis. Thus,
although the effect of L-arginine on the susceptibility of
hemorrhaged animals to wound infection has not been
determined our results suggest that the attenuated wound
immune function might result in a decreased rate of
wound infections. This hypothesis is further supported by
the previous finding that the restored cytokine release of
wound immune cells on the fifth postoperative day fol-
lowing hemorrhage results in an unaltered rate of wound
infections compared to sham-operated animals [13, 26]. It
remains unknown, however, whether other functional
aspects of wound immune cell function, i.e. depressed
phagocytic activity [13] are improved by L-arginine.
It should be noted that administration of L-arginine in
sham-operated animals did not alter systemic immune
responses or organ blood flow in previous studies [10–12].
Although the effect of L-arginine on wound immune func-
tion in sham-operated animals was not determined these
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results support the notion that in normal animals there is
an adequate amount of endogenous L-arginine to saturate
NOS activity [6, 11]. Administration of L-arginine in the
early stage of resuscitation following hemorrhage, how-
ever, ameliorated the depressed local wound immune
function, restored systemic cell-mediated immune re-
sponses, and maintained cardiovascular responses [11,
12]. Those findings suggest that the levels of endogenous
L-arginine might decrease following adverse circulatory
conditions, and thus administration of the exogenous sub-
strate serves to increase or replete those stores. Whether
the decreased endogenous levels of L-arginine following
hemorrhage are due to the decreased availability of this
amino acid or due to increased arginase activity remains
to be determined.
The precise mechanism responsible for improving the
hyporesponsiveness of wound cells following hemorrhagic
shock by L-arginine administration seen in the present
study remains unknown. Several studies suggest that hem-
orrhage causes a decrease in organ blood flow which
results in regional hypoxia [4, 38]. Regional hypoxia
appears to be an important endogenous mediator of the
immunological response to injury [4]. In this regard, L-
arginine, the substrate for nitric oxide synthase, has
recently been shown to restore the depressed blood flow in
various organs, i.e. liver, spleen, intestine, following trau-
ma-hemorrhage [2]. The present study further extends
those findings as evidenced by restoration of the de-
pressed skin and muscle blood flow in L-arginine-treated
animals following hemorrhagic shock. The increased skin
and muscle blood flow in L-arginine-treated animals
might attenuate the decreased subcutaneous wound
oxygen tension thereby attenuating wound immune cell
function in those animals following hemorrhage. In this
respect, depressed oxygen tension at the wound site has
previously been shown to increase the rate of wound
infection [39]. Similarly, the resistance to infection of
musculocutaneous flaps in dogs was decreased in animals
housed in 12% oxygen compared to normoxic conditions
[40]. In addition, IL-6 levels in the tissue around the inci-
sion were decreased in L-arginine-treated mice after hem-
orrhage. In this respect, studies by Mateo et al. [14] sug-
gest that IL-6 is one of the major contributors to the inhib-
itory effects of wound fluid on fibroblast proliferation.
Thus, L-arginine might directly or indirectly decrease the
hyperinflammation at the wound. Alternatively, locally
increased levels of IL-10 in the wound fluid might prevent
an increased inflammatory response thereby protecting
wound immune cell function in vitro. Ertel et al. [41]
demonstrated an attenuated proinflammatory cytokine
release following in vivo administration of IL-10 after
endotoxemia. Furthermore, addition of IL-10 to the cul-
ture medium of PBMCs decreased the stressed induced
proinflammatory cytokine release [42]. Those findings
further support the notion that elevated IL-10 levels
might decrease shock-induced immunodysfunction.
In summary, the present study demonstrates that ad-
ministration of L-arginine during resuscitation following
hemorrhagic shock attenuates the depressed wound exu-
date cell function in vitro and decreases the inflammatory
response in vivo potentially by restoring the depressed
muscle and skin blood flow. Furthermore, the antiinflam-
matory cytokine IL-10 which is elevated in the wound
fluid of hemorrhaged animals following L-arginine ad-
ministration might contribute to the improved wound
immune cell response under such conditions. Since de-
pressed wound immune cell function has been shown to
be associated with an increased rate of wound infections
our results suggest that L-arginine treatment might de-
crease the rate of wound infections following severe blood
loss. Therefore, attempts to improve immune cell func-
tion at the wound site by administration of the physiologi-
cal amino acid L-arginine might represent a helpful and
useful approach for decreasing the incidence of wound
infections in trauma victims.
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